Previous Masterclass Agendas
Europe 2019
November 15
SESSION 1 – FRIDAY, NOVEMBER 15, 2019
9:00 am – 4:30 pm
Agenda
WELCOME + INTRODUCTION
SESSION TOPICS
Pathogenesis and how it relates to drug
Phenotypes and assessment of psoriasis and psoriatic arthritis
Pustular psoriasis
Comorbidities: Focus on metabolic syndrome and mental health
Optimizing the use of topicals and standard systemics
Optimizing the use of biologics
Challenging cases workshop: An integrated learning experience
Paradoxical reactions to biologics
Comprehensive management of psoriasis
CLOSING COMMENTS
November 16
SESSION 2 – SATURDAY, NOVEMBER 16, 2019
9:00 am – 1:00 pm
Agenda
WELCOME + INTRODUCTION
SESSION TOPICS
What did we learn? Reflections on challenging cases workshop from day 1
Challenging cases workshop – presented by delegates
Ambition in psoriasis – Striving for more
CLOSING COMMENTS
India 2019
June 29
SESSION 1 – SATURDAY, JUNE 29, 2019
10:00 am – 6:00 pm
Agenda
REGISTRATION, PRE-TEST AND NETWORKING
OPENING COMMENTS
Novartis introduction and overview of program
Welcome and introduction to the International Psoriasis Council
PATHOPHYSIOLOGY OF PSORIASIS – ROLE OF CYTOKINES AND POTENTIAL TARGETS
Evolution of understanding of the cytokines; role of IL-13 and TNFi; differential role of IL-17
OVERVIEW OF PSORIASIS AND COMORBIDITIES
Epidemiology of plaque psoriasis
BREAK
THE CLINICAL SPECTRUM OF PSORIASIS
Screening and assessment, pros and cons and assessment tool, emphasis on PASI
TREATMENT GOALS
Evolution of management from PASI 75 to PASI 100
NON-BIOLOGIC SYSTEMIC AGENTS
Methotrexate, cyclosporine, apremilast and others
LUNCH
BIOLOGICS IN PSORIASIS
Anti-TNFs
IL 12/23
IL-17 and IL-23
MONITORING AND MAINTENANCE OF RESPONSE
Follow up of the patient; lab and clinical parameters
CHALLENGES IN THE LONG TERM MANAGEMENT OF PSORIASIS
Long term efficacy of biologics; reduction/loss of response over a period of time; how to approach such a patient and manag
BREAK
CHALLENGING CASES: IPC MASTERCLASS 1.0 EXPERIENCES
CLOSING COMMENTS
June 30
SESSION 1 – SUNDAY, JUNE 30, 2019
9:00 am – 3:00 pm
Agenda
BREAKFAST AND NETWORKING
COMPLEXITIES OF DIAGNOSIS AND TREATMENT – BREAK OUT SESSIONS
Assessment scoring
Treatment failures
Treatment guidelines
CHALLENGING CASES: PRESENTED BY THE FACULTY
Case 1: Palmoplantar
Case 2: Scalp
Case 3: Psoriasis with heart failure
BREAK
NEW TREATMENT PARADIGMS IN THE MANAGEMENT OF PSORIASIS
Role of PDE-4i and P19 as a target
TREATING BEYOND THE SKIN
Focus on psoriatic arthritis: Risk factors, screening and diagnosis
LUNCH
MANAGING COMORBIDITIES AND PSORIASIS IN SPECIAL POPULATIONS – BREAK OUT SESSIONS
Topic 1: Children
Topic 2: Women
Topic 3: Comorbidities
EVALUATION AND CLOSING
Latin America 2021
25 MAYO
1ª MÓDU
Masterclass 2021 Programa: Actualizaciones en Psoriasis
Timezones:
Guatemala City/San Jose: 12:00 pm – 2:00 pm
Bogota/Mexico City: 1:00 pm – 3:00 pm
Santiago/Asunción: 2:00 pm – 4:00 pm
Buenos Aires/São Paulo: 3:00 pm – 5:00 pm
Agenda
Introducciones
Claudia de la Cruz
Actualizaciones en Fisiopatología
Matías Maskin
Global Psoriasis Atlas (GPA) y Epidemiologia en LATAM
Chris Griffiths
Severidad en Psoriasis: Categorías
Peter van de Kerkhof
Metas de tratamiento, Target to treat
Cristina Echeverría
Discusión
Presentación de casos clínicos
Claudia de la Cruz, Cristina Echeverría, César González, Matías Maskin, Peter van de Kerkhof
1 JUNIO
2º MÓDULO
Masterclass 2021 Programa: Actualizaciones en Psoriasis
Timezones:
Guatemala City/San Jose: 12:00 pm – 2:00 pm
Bogota/Mexico City: 1:00 pm – 3:00 pm
Santiago/Asunción: 2:00 pm – 4:00 pm
Buenos Aires/São Paulo: 3:00 pm – 5:00 pm
Agenda
Actualizaciones Clínicas
Enrique Rivas
Actualizaciones en Psoriasis Ungueal y Pustulosa
César González
Actualizaciones en Comorbilidades; manifestaciones extracutáneas
Ron Vender
Actualizaciones en Artritis Psoriática
Alice Gottlieb
Discusión
Presentación de casos clínicos
Claudia de la Cruz, Cristina Echeverría, César González, Angela Londoño, Enrique Rivas, Peter van de Kerkhof
8 JUNIO
3º MÓDULO
Masterclass 2021 Programa: Actualizaciones en Psoriasis
Timezones:
Guatemala City/San Jose: 12:00 pm – 2:00 pm
Bogota/Mexico City: 1:00 pm – 3:00 pm
Santiago/Asunción: 2:00 pm – 4:00 pm
Buenos Aires/São Paulo: 3:00 pm – 5:00 pm
Agenda
Actualización en Terapias Convencionales: Tópicos
Matías Maskin
Actualización en Terapias Sistémicas Convencionales: Metotrexato (oral, inyectable), qué hay de nuevo
Angela Londoño
Actualización en Terapias Sistémicas Convencionales: Fototerapia (PUVA; NBUVB; EXCIMER), qué hay de nuevo
César González
Nuevas Terapias Orales: Apremilast, inhibidores JAK, Tyk2
Cristina Echeverría
Discusión
Presentación de casos clínicos
Claudia de la Cruz, Cristina Echeverría, César González, Angela Londoño, Matías Maskin, Peter van de Kerkhof
15 JUNIO
4º MÓDULO
Masterclass 2021 Programa: Actualizaciones en Psoriasis
Timezones:
Guatemala City/San Jose: 12:00 pm – 2:00 pm
Bogota/Mexico City: 1:00 pm – 3:00 pm
Santiago/Asunción: 2:00 pm – 4:00 pm
Buenos Aires/São Paulo: 3:00 pm – 5:00 pm
Agenda
Actualización en Terapias Biológicas: bloqueadores Anti TNF alfa
Claudia de la Cruz
Actualización en Terapias Biológicas: Biosimilares
Cristina Echeverría
Actualización en Terapias Biológicas: Inhibidores de IL17
Enrique Rivas
Inhibidores de Il12 y 23
Matías Maskin
Discusión
Presentación de casos clínicos
Claudia de la Cruz, Cristina Echeverría, César González, Angela Londoño, Matías Maskin, Enrique Rivas, Peter van de Kerkhof
22 JUNIO
5º MÓDULO
Masterclass 2021 Programa: Actualizaciones en Psoriasis
Timezones:
Guatemala City/San Jose: 12:00 pm – 2:00 pm
Bogota/Mexico City: 1:00 pm – 3:00 pm
Santiago/Asunción: 2:00 pm – 4:00 pm
Buenos Aires/São Paulo: 3:00 pm – 5:00 pm
Agenda
Actualización en Terapias Biológicas: lo nuevo (inhibidores de IL36)
César González
Psoriasis y salud mental
Karina Malvido
Psoriasis y Covid I: Cómo afecta la pandemia a nuestros pacientes
Claudia de la Cruz
Psoriasis y Covid II: VACUNAS en latam
Juan Bravo Ojeda
Discusión
Mesa redonda: Cómo escoger el Tratamiento adecuado para mi paciente
Claudia de la Cruz, Cristina Echeverría, César González, Karina Malvido, Juan Bravo Ojeda
Middle East and North Africa 2021
JANUARY 15
DAY 1 – FRIDAY, JANUARY 15, 2021
Epidemiology, Pathogenesis and Comorbidities
Timezones:
- Nouakchott: 11:00 am – 1:00 pm
- Cairo/Khartoum/Tripoli: 1:00 – 3:00 pm
- Rabat/Tunis: 12:00 – 2:00 pm
- Kuwait City: 2:00 – 4:00 pm
- Tehran: 2:30 – 4:30 pm
Agenda
OPENING COMMENTS
Mahira Hamdy El Sayed, MSc, MD
The Global Psoriasis Atlas: Epidemiology and access
Christopher EM Griffiths, OBE, MD, FRCP, FMedSci
Pathophysiology of psoriasis and implications for treatment
Mohamed El-Komy, MD
CLINICAL PRESENTATIONS OF PSORIASIS AS SYSTEMIC DISEASE
Case 1: Psoriatic Arthritis
Ahmed Nassar, Ain Shams University
Case 2: Cardiovascular
Miriam Samir, Ain Shams University
Case 3: Obesity with diabetes
Aya AlOrbani, Cairo University
CLOSING
JANUARY 22
DAY 2 – FRIDAY, JANUARY 22, 2021
Phenotypes, Disease Assessment and Treatment Targets
Timezones:
- Nouakchott: 11:00 am – 1:00 pm
- Cairo/Khartoum/Tripoli: 1:00 – 3:00 pm
- Rabat/Tunis: 12:00 – 2:00 pm
- Kuwait City: 2:00 – 4:00 pm
- Tehran: 2:30 – 4:30 pm
Agenda
Every patient has his own psoriasis
Peter van de Kerkhof, MD, PhD
Erythroderma – Case + Panel discussion
Mahira Hamdy El Sayed, MSc, MD
Pustular psoriasis
Nejib Doss, MD
Pediatric psoriasis
Mahira Hamdy El Sayed, MSc, MD
Audience Q & A
Faculty
JANUARY 29
DAY 3 – FRIDAY, JANUARY 29, 2021
Treatment Options and Management
Timezones:
- Nouakchott: 11:00 am – 1:00 pm
- Cairo/Khartoum/Tripoli: 1:00 – 3:00 pm
- Rabat/Tunis: 12:00 – 2:00 pm
- Kuwait City: 2:00 – 4:00 pm
- Tehran: 2:30 – 4:30 pm
Agenda
How to treat patients with mild disease
Mahira Hamdy El Sayed, MSc, MD
What to do when topicals are not appropriate anymore
Mohamed El-Komy, MD
How to treat patients with severe psoriasis of the skin
Peter van de Kerkhof, MD, PhD
How to treat psoriasis with comorbidities
Christopher EM Griffiths, OBE, MD, FRCP, FMedSci
Audience Q & A
Faculty
FEBRUARY 5
DAY 4 – FRIDAY, FEBRUARY 5, 2021
Specific Areas and Specific Situations
Timezones:
- Nouakchott: 11:00 am – 1:00 pm
- Cairo/Khartoum/Tripoli: 1:00 – 3:00 pm
- Rabat/Tunis: 12:00 – 2:00 pm
- Kuwait City: 2:00 – 4:00 pm
- Tehran: 2:30 – 4:30 pm
Agenda
Discussion: Biosimilars
Christopher EM Griffiths, OBE, MD, FRCP, FMedSci, moderator
Mahira Hamdy El Sayed, MSc, MD, Omid Zargari, MD, FAAD, panelists
Discussion: Psoriasis in women
Peter van de Kerkhof, MD, PhD, moderator
Mahira Hamdy El Sayed, MSc, MD, panelist
Nails and Scalp
Mohamed El-Komy, MD
Pruritis + other symptoms
Nejib Doss, MD
Audience Q & A
Faculty
FEBRUARY 12
DAY 5 – FRIDAY, FEBRUARY 12, 2021
Challenging Cases
Timezones:
- Nouakchott: 11:00 am – 1:00 pm
- Cairo/Khartoum/Tripoli: 1:00 – 3:00 pm
- Rabat/Tunis: 12:00 – 2:00 pm
- Kuwait City: 2:00 – 4:00 pm
- Tehran: 2:30 – 4:30 pm
Agenda
Challenging cases by attendees
Asma Ghanem Bashir, Libya
Moneer Omran Bugrein, Libya
Sahar Dadkhahfar, Iran
Manal Elmubarak, Sudan
Mostafa Khalaf, Egypt
Alia Ramadan, Egypt
The future of psoriasis
Peter van de Kerkhof, MD, PhD
Personalized medicine
Christopher EM Griffiths, OBE, MD, FRCP, FMedSci
Key learnings and program closing
Mahira Hamdy El Sayed, MSc, MD, moderator
